EASL Studio Podcast: Liver cancer in 2022: Wrap-up & outlook

Results from current clinical trials are rapidly evolving, with mixed results. In this EASL Studio the faculty discuss:why certain trials have failed whereas others have succeeded,what we have learned about the connection between overall survival and progression-free survival as endpoints, andhow the systemic therapy of HCC has evolved.FacultyProf. Peter Galle (Moderator)Prof. Bruno Sangro (Faculty)Dr Anna Saborowski (Faculty)Prof. Arndt Vogel (Faculty)Related episodesS2E15 – JHEP Live – The best animal model for HCC — lost in translationSpecial Edition: Highlights of the Liver Cancer Summit 2022Policy Dialogues Episode 3: Liver Cancer: The risk of ignoranceAll EASL Studio Podcasts are available on EASL Campus.

Om Podcasten

The EASL Podcast collection includes educational podcasts and audio versions of digital EASL offerings. The ASK EASL Podcasts: Ongoing series of educational podcasts. EASL Studio: Your weekly hepatology broadcast news.